CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study
Authors
D Aletaha
DT Felson
+27 more
DT Felson
E Baecklund
Elizabeth C Hsia
Eric L Matteson
F Wolfe
FC Arnett
Frederick T Murphy
G Wells
GA Wells
J Askling
JF Fries
Jonathan Kay
Josef S Smolen
JS Smolen
JS Smolen
JS Smolen
JS Smolen
Jürgen Wollenhaupt
MH Buch
Mittie Doyle
ML Prevoo
Norman Gaylis
OM Ni Mhuircheartaigh
PL Riel van
Robert Landewé
Stephen Xu
Yiying Zhou
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs13075-015-...
Last time updated on 05/06/2019